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Abstract
The production of reactive oxygen species (ROS) from the inner mitochondrial membrane is one of many fundamental
processes governing the balance between health and disease. It is well known that ROS are necessary signaling molecules in
gene expression, yet when expressed at high levels, ROS may cause oxidative stress and cell damage. Both hypoxia and
hyperoxia may alter ROS production by changing mitochondrial Po2 (PmO2 ). Because PmO2 depends on the balance
between O2 transport and utilization, we formulated an integrative mathematical model of O2 transport and utilization in
skeletal muscle to predict conditions to cause abnormally high ROS generation. Simulations using data from healthy
subjects during maximal exercise at sea level reveal little mitochondrial ROS production. However, altitude triggers high
mitochondrial ROS production in muscle regions with high metabolic capacity but limited O2 delivery. This altitude roughly
coincides with the highest location of permanent human habitation. Above 25,000 ft., more than 90% of exercising muscle
is predicted to produce abnormally high levels of ROS, corresponding to the ‘‘death zone’’ in mountaineering.
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Introduction
It is well accepted that cellular hypoxia [1–4] triggers a
constellation of biological responses involving transcriptional and
post-transcriptional events [5,6] through activation of cellular
oxygen sensors. This includes generation of reactive oxygen
species (ROS). Yet, current knowledge on the quantitative
relationships between mitochondrial Po2 (PmO2 ), hypoxia-induced
cellular events, and on the release of ROS from the inner
mitochondrial membrane, is minimal. For example, how low
PmO2 must be to trigger abnormally high ROS generation has not
yet been identified. Furthermore, the levels of PmO2 at rest and
during exercise are unknown, although myoglobin-associated Po2
has been measured in intact exercising humans [7,8], and is
reported to be 3–4 mm Hg, implying that PmO2 is likely even
lower. There are promising new approaches being developed to in
vivo assessment of PmO2 [9].
Recently, we extended a prior model describing O2 transport
from the air to the mitochondria as an integrated system limiting
maximal oxygen uptake _VO2 max [10,11] to also include the
contribution to overall impedance to O2 flow from the above-zero
PmO2 required to drive mitochondrial respiration [12]. This was
accomplished by including an equation for the hyperbolic
relationship between mitochondrial Po2 and mitochondrial _VO2
as shown by Wilson et al. [13] and confirmed more recently by
Gnaiger’s group [14,15]. This has enabled the prediction of PmO2
as a balance between the capacities for muscle O2 transport and
utilization [12,16]. In addition, we have expanded this model by
now allowing for functional heterogeneity in both lungs and
muscle [16], which had previously (and reasonably) been taken to
be negligible in health. This was done to enable application to
disease states. Since mitochondrial ROS generation is affected by
cellular oxygenation, this integrative model may afford the
opportunity for better understanding the quantitative relationship
between O2 transport, mitochondrial respiration and ROS
generation, provided we have an understanding of the relationship
between PmO2 and ROS formation.
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Recent modeling and experimental studies on mitochondrial
ROS production under hypoxia and re-oxygenation [17–19] have
proposed an inherent bi-stability of Complex III, i.e. coexistence of
two different steady states at the same external conditions: one
state corresponding to low ROS production, and a second
potentially dangerous state with high ROS production. Tempo-
rary deprivation of oxygen could switch the system from low to
high ROS production, thus explaining the damaging effects of
hypoxia-re-oxygenation. This recently proposed model provides a
conceptual basis for the abnormally high ROS production
observed both in hyperoxia [20,21] and hypoxia [1–4] and has
the ability to predict the quantitative relationship between ROS
generation and PmO2 .
In this paper, we build upon these previous but separate models
of O2 transport as a physiological system and mitochondrial
metabolism as a biochemical system, and have linked them
through their common variables, PmO2 and
_VO2 , establishing one
integrated model to predict PmO2 and mitochondrial ROS
production. Specifically, we integrate the physiological model of
the oxygen pathway predicting PmO2 from the balance between
O2 transport and mitochondrial O2 utilization [10–12,16] with the
model of electron and proton transport in the mitochondrial
respiratory chain, and the ROS production associated with this
transport [17–19], thereby predicting the rate of ROS production
as a function of PmO2 and
_VO2 . The former model is referred to
below as the O2 pathway model, and the latter as the
mitochondrial ROS prediction model.
In addition to describing the integrated modeling system, we
present estimates of ROS generation in exercising muscle of
healthy subjects at different altitudes at and above sea level using
O2 transport data from Operation Everest II [22] and published
mitochondrial kinetic data in normal human muscle (discussed in
[17]). We found that at sea level, O2 transport at maximal exercise
is sufficient to keep PmO2 high enough that mitochondrial ROS
generation is not significantly increased. However, exercise at high
altitude is predicted to significantly increasing ROS generation,
agreeing with experimental data collected under these conditions
[23–25].
Materials and Methods
Oxygen pathway model
The modeling of O2 transport and utilization [10–12] adopted
in the current article relies on the concept that maximal
mitochondrial O2 availability is governed by the integrated
behavior of all steps of the O2 transport and utilization system
rather than being dominated by any one step. Building on the
work of DeJours [26], and Weibel et al [27], it was previously
shown [10,11] how each step (ventilation, diffusion across the
alveolar wall, circulation, diffusion from the muscle capillaries to
the mitochondria, and finally, oxidative phosphorylation itself)
contributes quantitatively to the limits to maximum O2 uptake
( _VO2 max). The model is based on the principle of mass
conservation at every step, and uses the well-known mass
conservation equations for each step as laid out by Weibel et al
[28]. Given the oxygen transport properties of the lungs, heart,
blood and muscles, and incorporating the (hyperbolic) mitochon-
drial respiration curve that relates mitochondrial _VO2 to
mitochondrial Po2 [13–15] the model computes how much O2
can be supplied to the tissues ( _VO2 ), and the partial pressures of
oxygen at each step (i.e. alveolar (PAo2 ), arterial (PaO2 ), venous
(PvO2 ), and mitochondrial (PmO2 )). This construct [12] leads to a
system of five equations, each describing mass conservation
equations governing O2 transport (Eqs. (1)–(4)) and utilization
(Eq. (5)), with the five unknowns also mentioned above.
_VO2~
_VI :FIo2{ _VA:FAo2 ð1Þ
D O2½  tð Þ
dt
~
DL
TL: _Q
: PAo2{PCo2 (t)
 
ð2Þ
_VO2~
_Q CaO2{CvO2
 
ð3Þ
D O2½  tð Þ
dt
~
DM
TM : _Q
: PCo2 (t){PmO2
 
ð4Þ
_VO2~
_V max:PmO2
(PmO2zP50)
ð5Þ
However, this system ignores heterogeneity of ventilation/
perfusion ( _VA= _Q) ratios in the lung, and heterogeneity of
metabolism/perfusion ( _VO2=
_Q) ratios in the muscle. This is laid
out in detail in [16], and in the current article, consideration of
typical, normal degrees of lung and muscle heterogeneity has been
incorporated. The original 5-equation model [12] also failed to
take into account that not all of the cardiac output flows to the
exercising muscles. Allowance for blood flow to, and O2 utilization
by, non-exercising tissues has accordingly also now been
incorporated into the system described in [16] and is used here.
Parameters of the O2 pathway model
The most complete data set with respect to O2 pathway
conductances during exercise at altitude (ventilation ( _VA), cardiac
output ( _Q), lung (DL) and muscle (DM) diffusional conductances,
[Hb]) comes from Operation Everest II [22], but even here,
measurements were made only at sea level, and at barometric
pressures equivalent to four specific altitudes of 15,000 ft.,
20,000 ft., 25,000 ft. and 29,000 ft. Because we wished to simulate
the entire altitude domain from sea level to the Everest summit, we
used the Operation Everest II data to interpolate parameter values
at intervening altitudes. Additional input parameters are required
for the analysis. These include: a) maximal muscle mitochondrial
metabolic capacity ( _V max), b) mitochondrial P50 i.e., the Po2 at
which mitochondrial respiration is half-maximal, c) dispersion of
ventilation/perfusion ratios in normal lungs, d) dispersion of
metabolism/perfusion ratios in muscle, and e) an estimate of total
blood flow to non-exercising tissues and their corresponding _VO2 .
For _V max, we chose a value 20% higher than the observed sea
level maximal _VO2 in the Operation Everest II subjects, and this
came to 4.58 L/min. The justification is that in healthy fit
subjects, _VO2 max is O2 supply-limited at sea level, since it
increases when 100% O2 is breathed [29,30]. This demonstrates
that mitochondrial metabolic capacity is clearly greater than sea
level _VO2 max. For mitochondrial P50, a value of 0.14 mm Hg
was chosen. This is the mitochondrial P50 value used in the ROS
prediction model described below [17–19], and is close to reported
values measured in vitro [14,15]. A representative normal level of
Impact of Mitochondrial PO2 on ROS Generation
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ventilation/perfusion heterogeneity (i.e., Log SD _Q~0:5) was
used, since normal subjects display Log SD _Q values of between
0.3 and 0.6 [31], increasing slightly with exercise. Log SD _Q is the
second moment (dispersion) of the perfusion distribution on a
logarithmic scale and has been used to quantify _VA= _Q heteroge-
neity for about 40 years [32–34]. For _VO2=
_Q heterogeneity in
muscle, there is very limited information. From a new technique
based on near-infrared spectroscopy and currently in develop-
ment, the corresponding dispersion in muscle appears to be about
0.1 (Vogiatzis et al, J. Applied Physiol, under revision), and this
was used.
Finally, to allow for non-exercising tissue perfusion and
metabolism we used typical normal resting values of cardiac
output and _VO2 (specifically, non-exercising total tissue blood flow
equal to 20% of maximal sea level cardiac output, and _VO2 of
300 ml/min).
Mitochondrial ROS prediction model
The mitochondrial ROS prediction model [17–19] considered
in this study accounts for: i) Respiratory complex I that oxidizes
NADH and reduces ubiquinone (Q), translocating H+; ii)
Respiratory complex II that also reduces Q, oxidizing succinate
to fumarate; iii) Respiratory complex III, the net outcome of which
is to oxidize ubiquinol, reducing cytochrome c and translocating
H+; iv) Respiratory complex IV that oxidizes cytochrome c,
reducing molecular oxygen to H2O and translocating H+; and, v)
The H+ gradient utilization for ATP synthesis in respiratory
complex V. NADH consumed by complex I is produced in the
several reactions of the TCA cycle leading from pyruvate to
succinate, and from fumarate to oxaloacetate.
This model consists of a large system of ordinary differential
equations that simulate the processes mentioned above based on
the general principle of the law of mass action. Simulating the
redox (from reduced/oxidized) reactions between the electron
carriers constituting complexes I and III, the model takes into
account that the carriers occupy fixed positions and have fixed
interactions in the space of a respiratory complex. The variables of
this model are the concentrations of redox states of the complex.
Each redox state of the complex is a combination of redox states of
the electron carriers constituting it. Since a carrier can be in one of
the two redox states (reduced or oxidized), the number of variables
is 2n, where n is the number of electron carriers fixed in the space
of the complex. The model accounts also various forms of the
complexes created by binding/dissociation of ubiquinone/ubiqui-
nol. The other respiratory complexes are accounted for in a
simplified form, assuming that the electrons that leave complex III
ultimately reduce oxygen. Such a reaction is taken to be a
hyperbolic function of oxygen concentration and proportional to
the concentrations of forms able to donate an electron.
The mechanism of electron transport includes steps where
highly active free radicals are formed. These radicals are capable
of passing their unpaired high-energy electron directly to oxygen,
thus producing superoxide anion radical and then the whole
family of ROS such as OH radical and peroxides. The system of
equations that constitutes this model is described in [17–19].
Parameter values for the respiratory chain used here were
obtained from experimental studies [17] of normal mitochondrial
function. The model calculates the levels of free radicals of the
electron carriers constituting the respiratory chain (such as
semiquinone radical). These radicals, normally formed in the
process of electron transport, are responsible for ROS production.
These levels are presented here as indicators of ROS production
rate.
Overall, the mitochondrial ROS generation model produces
two distinct patterns of response to PmO2 at maximum exercise, as
displayed in Figure 1. One pattern (HR) reflects above normal
high ROS generation and the other (LR) reflects little or normal
ROS generation. Briefly, the figure shows the rate of mitochon-
drial ROS production expressed as concentration of semiquinone
radicals (nmol/mg) at Qo site (ubiquinone binding site to complex
III at the outer side of the inner mitochondrial membrane) of
mitochondrial complex III (y-axis) against time (x-axis) for four
different values of PmO2 , indicated in Figure 1.
Note that here, PmO2 is expressed not as absolute values but as
multiples of mitochondrial P50 (in this case from 0.2?P50 to
100?P50). For pattern LR, there is essentially no change in ROS
generation, and this corresponds to the two PmO2 values
exceeding the P50 in Figure 1. Pattern HR is seen in the two
examples where PmO2 is less than P50, and here a large, almost 10-
fold increase in ROS generation occurs. In fact, the switch occurs
abruptly when PmO2
~2=3:P50. The high sensitivity of mitochon-
drial ROS production to restrictions of oxygen transport, and thus
to low PmO2 , is a consequence of multistationarity, the mecha-
nisms of which are considered in detail in previous publications
[17,18]. Finally, the increase in ROS generation persists after
cessation of exercise, and the lower the PmO2 , the longer the
persistence time, also shown in Figure 1.
The non-linear bi-stability inherent to mitochondrial ROS
prediction model [17–19] accounts for the abrupt change of
mitochondrial ROS production rate with a change of external
(with respect to the respiratory chain) conditions. In principle such
a change can be irreversible (in accordance with the phenomenon
of bistability investigated in [17–19]), but in the considered case it
reverses with a delay. The delay results from slow oxidation of
Figure 1. Dynamics of ROS production (expressed as SQo
produced, normalized to total complex III abundance (taken as
0.4 nmol/mg mitochondrial protein)) at four steady state
concentrations of oxygen (expressed as mitochondrial Po2
relative to P50, the oxygen partial pressure at the half-maximal
rate of respiration). Before and after exercise, rest is simulated (no
ATP hydrolysis, proton gradient dissipates only due to membrane leak).
Between 2 and 6.6 min, exercise is simulated (membrane proton
gradient dissipates due to ATP hydrolysis and ATP synthase activity).
Overall, ROS production falls into two distinct patterns: one (HR, seen
when PmO2=P50v0:67) reflects high ROS generation and the other (LR,
when PmO2=P50§0:67) reflects little or no ROS generation compared
to rest. Note post-exercise persistence of high ROS generation,
especially at the lowest PmO2 to P50 ratio.
doi:10.1371/journal.pone.0111068.g001
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ubiquinol to ubiquinone, which is necessary to activate the Q-cycle
in respiratory complex III.
Procedure for model integration
The use of PmO2 normalized to P50 reflects the fact that while
the model predicts different ROS generation rates at different
PmO2 values for a given mitochondrial respiration curve of any
particular P50, when PmO2 is the same fraction of P50, ROS
generation is the same even if absolute PmO2 and P50 are different.
For example, if PmO2~0:1 and P50 = 0.2, ROS generation would
be the same as that computed when PmO2~0:2 and P50 = 0.4,
because in both cases, PmO2=P50 is the same ( = 0.5). This is
illustrated in Figure 2, panels 1 and 2. In Panel 1, two
mitochondrial respiration curves are drawn with the above
different absolute P50 values (but the same _V max values). Using
the above PmO2 values,
_VO2 in both cases would be the same at
1=3: _V max, shown by the solid circles. Panel 2 replots these data
normalizing the x-axis by P50 for each case, and normalizing the
y-axis by _V max in each case.
These normalized respiration curves now overlie one another,
and the important point is that the relative PmO2 values in the two
cases are identical and the relative _V max values are also identical,
as will be ROS generation by the two regions. In a similar fashion,
it is important to recognize that different muscle tissue regions may
have different numbers of mitochondria and thus different _V max
values even if P50 were uniform across regions. The normalization
of _VO2 to _V max is thus necessary in order to compare different
regions. For example, if _VO2 were the same at 0.2 units in two
regions (and P50 were also the same in both regions) but
_V maxwere different at 0.3 and 0.6 units in these two regions
(Figure 2, panel 3), _VO2

_V maxin the first region would be 0.67
but only 0.50 in the second region. When the data are replotted to
normalize PmO2 (x-axis) to P50 0 and _VO2 (y-axis) to _V max
(Figure 2, panel 4), the two solid circles now separate. Thus,
despite similar absolute _VO2 values, and the same P50, the second
region lies lower on the mitochondrial respiration curve than the
first region.
Integration of the models
Recall that the oxygen pathway model consists of five equations,
the solutions to which define the partial pressures of O2 at each
step between the air and the mitochondria as well as the mass flow
of O2 through the system ( _VO2 max). Key input variables for this
model are mitochondrial _V max and P50 (along with all of the
conductances of the O2 pathway). The key output variable for
linkage to the metabolic model is _VO2 max (as a fraction of
_V max). Thus, once the O2 pathway model has been run for any
Figure 2. Importance of normalizing both actual _VO2 to mitochondrial _V max and actual mitochondrial Po2 (PmO2 ) to mitochondrial
P50 when _V max and/or P50 may vary within or between muscles. Panel 1: Example of two muscles (A & B) with the same _V max but different
P50 that happen to have the same absolute _VO2 (closed circles). Although PmO2 is lower in A than B, normalization of both axes (Panel 2) shows that
in this case, PmO2 relative to P50 is the same, and this means that ROS generation will be the same for A and B. Panel 3: Example of two muscles (A &
B) with the same P50 but different _V max that again happen to have the same absolute _VO2 (closed circles). PmO2 is again lower in A than B, but
normalization of both axes (Panel 4) shows that PmO2 relative to P50 is lower in A than B, and this means that ROS generation will be high for A and
normal for B.
doi:10.1371/journal.pone.0111068.g002
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set of input variables, the metabolic model accepts as inputs from
the O2 pathway model _VO2 max, _V max, and mitochondrial P50,
which also then defines mitochondrial Po2 from the hyperbolic
mitochondrial respiration curve.
After scaling these variables to harmonize the units between the
two models ( _VO2 is in ml/min in the pathway model, but in
nanomoles/min/mg mitochondrial protein in the metabolic
model) the metabolic model is run, simulating mitochondrial
respiration, i.e. the electron flow that reduces the transported
oxygen to H2O. The principal outcome of the metabolic model for
the present purposes is the rate of generation of ROS at exercise
conditions for the given values of _VO2 max, _V max, P50 and
PmO2 .
Results
The main outcome of this study is allowing a quantitative
analysis of how the physiological O2 transport pathway [10–12]
affects mitochondrial ROS generation in muscle [17–19].
Figure 3 shows how maximal _VO2 and mitochondrial Po2 in a
homogeneous muscle will fall together with altitude, as computed
from the O2 pathway model. Figure 3 also displays the degree of
ROS generation as a function of mitochondrial Po2 computed
from the mitochondrial respiration model. As explained in [17–
19], ROS generation abruptly switches from low to high levels
when mitochondrial Po2 reaches a critical value of 2/3 of the P50
of the mitochondrial respiration curve – in Figure 3 at about
0.1 mm Hg since P50 is 0.14 mm Hg. In this case, the
corresponding altitude is 24,000 ft. above sea level. Thus, open
circles (altitudes less than 24,000 ft.) reflect a state of low ROS
generation, and closed circles (altitudes greater than 24,000 ft.)
reflect a state of high ROS generation. While Figure 3 shows the
outcome for a homogeneous muscle, in reality the muscles will not
be perfectly homogeneous, just as no random group of humans
will all have exactly the same height or weight. The important type
of heterogeneity for O2 transport in muscle is that of the ratio of
mitochondrial metabolic capacity ( _V max, reflecting ability to
consume O2) to blood flow ( _Q, reflecting O2 availability). Thus,
with heterogeneity, some muscle regions will have lower than
average _V max= _Q ratio, and other will have a _V max= _Q ratio
greater than average. Data on the extent of heterogeneity in
muscle are scarce due to lack of methods for its measurement, but
recent, unpublished estimates based on near-infrared spectroscopy
technology (Vogiatzis et al, J. Applied Physiol, under review)
suggest that a small amount of heterogeneity does exist.
When _V max= _Q is high (metabolic capacity high in relation to
O2 availability), mitochondrial Po2 will be low, and vice versa as
shown in Figure 4 (simulated for several altitudes from sea level
to 30,000 ft.). When expressed as the second moment of the
_VO2=
_Q distribution, on a log scale, the value is about 0.1. This can
be compared to the identically computed and well-established
index of ventilation/perfusion ( _VA= _Q) inequality in the normal
lung of 0.3–0.6 [31], which is generally regarded as small.
Figure 4 also shows the range of _V max= _Q ratios for a muscle
with normal heterogeneity (i.e., dispersion of 0.1) as from about
0.15 to about 0.36, pointing out the large range of mitochondrial
Po2 that this seemingly small amount of heterogeneity creates.
Thus, muscle regions with a high _V max= _Q ratio become
susceptible to high ROS generation before those with lower
_V max= _Q ratio. With the critical switch from low to high ROS
production occurring at a PmO2 of about 0.1 mm Hg, Figure 4
shows that with normal heterogeneity, the muscle regions with
highest _V max= _Q exhibit high ROS production already at
17,000 ft. altitude, and that at the summit of Mt. Everest (approx.
29,000 ft.), almost 100% of muscle regions will have switched to
high ROS production.
Figure 5A shows the consequences of normal muscle
_V max= _Q heterogeneity for the development of high ROS
production in the format of Figure 3. The important points
are: i) that due to the presence of high _V max= _Q regions, high
ROS generation is seen (in those regions) already at 17,000 ft., a
much lower altitude than for the homogeneous system (24,000 ft.),
and ii) that high ROS generation becomes more extensive with
further increases in altitude. Figure 5B shows the percentage of
muscle predicted to have high ROS production over the altitude
range from sea level to the Everest summit.
Discussion
The results displayed in Figures 3–5 are specific to the input
data used (Tables S1 and S2 in the supplementary on-line
material). While they take advantage of the most complete data set
available on humans exercising over a range in altitude from sea
level to the equivalent of the Everest summit, the quantitative
outcomes presented in this article would be different if a different
data set were used. This should be kept in mind when interpreting
the results presented. In addition, some specific, important data
are both scarce in the literature and uncertain. The most
important of these are the mitochondrial respiration curve
characteristics (here defined by two parameters, _V max and
P50), and the extent of heterogeneity in the distribution of blood
flow to muscle regions with different metabolic capacity.
With respect to the mitochondrial respiration curve character-
istics, in general, PmO2 is systematically higher for the lowest
_V max, and at any _V max, increasing mitochondrial P50 results in
systematically higher PmO2 values. Because of uncertainty in
_V max and P50 we carried out a sensitivity analysis that shows that
in normoxia, as _V max is varied from 10% to 20% to 30% above
measured _VO2 max, oxygen transport and utilization is unaffected
at 3.8 L/min. However, PmO2 varies somewhat (1.2, 0.7, 0.5 mm
Hg). At altitude, the effects were similar: at 15,000 ft. oxygen
Figure 3. Reduction of maximal _VO2 and mitochondrial Po2 in a
homogeneous muscle as a function of altitude, (solid line,
computed from the O2 pathway model) and degree of ROS
generation as a function of mitochondrial Po2 (computed from
the mitochondrial respiration model). Below 24,000 ft, ROS
production is low (open circles), but above 24,000 ft, ROS production
abruptly increases (closed circles).
doi:10.1371/journal.pone.0111068.g003
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consumption was invariant at 2.8 L/min and PmO2 was 1.9, 1.6,
1.3 mm Hg respectively; while at 30,000 ft. oxygen consumption
remained invariant at 1.4 L/min with PmO2 values of 0.07, 0.06,
0.06 mm Hg respectively. At any altitude, therefore, prediction of
ROS generation was not affected by this degree of uncertainty in
_V max.
When P50 was varied between 0.1 and 1.0 mm Hg, oxygen
utilization was minimally affected (3.8 to 3.6 L/min respectively)
while PmO2 increased from 0.5 to 3.7 mm Hg. Considered relative
to P50, which is what is important in ROS generation as discussed
above, PmO2=P50 decreased from 4.9 to 3.7. At 15,000 ft. oxygen
utilization fell from 2.8 to 2.7 L/min as P50 was raised from 0.1 to
1 mm Hg and PmO2 increased from 0.2 to 1.5 mm Hg. When
normalized to P50, PmO2 was invariant at 1.5?P50. At 30,000 ft.
oxygen utilization was unaffected as P50 was varied from 0.1 to
1 mm Hg (at 1.4 L/min), while PmO2 increased from 0.05 to
0.45 mm Hg. However, when normalized to P50, PmO2 was
invariant at 0.45?P50. Thus, variation in P50 over a 10-fold range
did not affect the outcome in terms of ROS generation.
While the particular results we report depend on the values we
took for these functions, the important point is the presentation of
the integrated model approach coupling physiological elements of
O2 transport with biochemical elements of oxidative phosphory-
lation stands, no matter what specific data are used to run it. A
graphical user interface to parameterize and simulate the
integrated model is freely available at https://sourceforge.net/
projects/o2ros.
Biological and clinical implications
It is of interest that our results suggest that ROS generation in
exercising normal muscle switches to high levels already at
17,000 ft., or about 5,000 m. This is the altitude above which
permanent human habitation does not occur [35], and also the
altitude above which humans experience inexorable loss of body
mass. It is easy to hypothesize a cause and effect relationship
between ROS and these findings, given the generally pro-
inflammatory effects of high ROS levels, but whether this is
indeed cause and effect or just coincidence remains to be
established. In the same vein, the widespread presence of high
ROS generation within muscle above 20,000 ft. and almost
uniform presence above 25,000 ft. coincides with what is
popularly termed the ‘‘death zone’’ in the mountaineering
community – altitudes where fatalities are common. Of course,
bitter cold, high winds, and hypoxia itself are likely contributors to
the high risk of death under these conditions, but it is possible that
high ROS production may be playing a role, not just in muscle but
perhaps also in critical organs such as the brain. There is a
growing body of literature [36–38] suggesting that endogenous
ROS at high concentrations are damaging to cells, while at lower
levels they are involved in activating important signaling pathways,
some of which relate to adaptation to hypoxia (angiogenesis, for
example where the promoter region of the critical angiogenic gene
VEGF has a binding site for H2O2 [39]. They also act as pro-
survival molecules regulating kinase-driven pathways [36,40]. A
recent systems analysis of abnormal muscle bioenergetics in
patients with Chronic Obstructive Pulmonary Disease (COPD)
[41] provides indirect evidence for a central role of cellular
hypoxia in explaining abnormal regulation of key metabolic
networks regulated by genetic and epigenetic mechanisms.
Moreover, there is evidence [42–44] of the role of nitroso-redox
disequilibrium explaining systemic effects in several chronic
disorders such as COPD, chronic heart failure and type II
diabetes. However, current knowledge of mitochondrial dysfunc-
tion [45–47] is still incomplete. The centrality of oxygen
metabolism in organisms leads to the notion that it is also
involved in other complex chronic diseases at essentially every
level of organization [5,48–50].
Potential applications of the integrated transport/metabolic
model, which has been presented here only in terms of healthy
humans at altitude, are envisioned in systems medicine with
analysis of the potentially greater degree of ROS generation
associated with impaired O2 availability in patients with diseases
such as COPD, heart failure, diabetes and peripheral vascular
disease. With the necessary input data, this could be done for
individual patients to assess the likelihood of high ROS generation
in muscle. In addition, the model may allow the prediction of the
benefits of exercise programs and pharmacological interventions in
these patients. Through its predictions, the current analysis may
open new avenues in assessment of the impact of impaired oxygen
exchange on increased mitochondrial ROS generation as well as
in evaluation of the consequences of oxidative stress on biological
Figure 4. Mitochondrial Po2 (PmO2 ) as a function of regional
ratios of metabolic capacity ( _V max) to blood flow ( _Q) at four
altitudes. The lower _Q (supply) is in relation to _V max (demand), the
lower is PmO2 at any altitude; also, PmO2 at any _V max

_Q ratio falls
with increasing altitude. Vertical dashed lines mark the normal range of
_V max

_Q. Both panels show the same data, but the lower panel
expands the y-axis in its lower range to show when ROS generation is
high (i.e., when PmO2v0:1 mm Hg). Below 17,000ft, ROS generation
remains low, but above this altitude, regions of normal muscle with
high _V max

_Q ratio generate high ROS levels, until at the Everest
summit, almost the entire muscle generates high ROS levels.
doi:10.1371/journal.pone.0111068.g004
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functions in different acute and chronic diseases [5,6]. While
prediction of mitochondrial ROS generation may be possible, it is
clear that the current integrated model addresses only the
relationships between determinants of cellular oxygenation and
mitochondrial ROS production. It does not attempt to deal with
other sources of ROS [51] or complexities of the redox system
such as the antioxidant resources that will modulate the biological
activity of ROS generated by exercise within muscle, and which
will thus affect oxidative stress. Accounting for such elements is
well beyond the scope of this article, but it’s a target for the future.
Conclusions
The integration of the two deterministic modeling approaches
considered in this study allows us to establish a quantitative
analysis of the relationships between the components of the O2
pathway [10–12,16] and mitochondrial ROS generation [17–19].
To this end, the simulations herein using data from exercising
normal subjects at sea level and altitude have shown that when
_VO2 is low (less than 40% of mitochondrial oxidative capacity) due
to impaired O2 transport, extremely low PmO2 values will develop,
which in turn may be associated with above normal ROS
production. This will occur when PmO2v2=3 of mitochondrial
P50. The current investigation may open new avenues for assessing
the impact of impaired oxygen transport on increased mitochon-
drial ROS generation as well as for evaluating the consequences of
oxidative stress on biological functions in both acute and in
chronic diseases [5,6].
Supporting Information
Table S1 Input parameters for the oxygen transport system.
Values interpolated from those measured during OEII (reference
at sea level, 15,000 ft, 20,000 ft, 25,000 ft and 29,000 ft).
(DOCX)
Table S2 Input parameters for the modeling of Cell Bioener-
getics and ROS production.
(DOCX)
Figure 5. Effect of altitude on ROS generation when considering typical values for lung andmuscle heterogeneities. A: Between 0 and
17,000 ft., ROS generation is within the normal range throughout the exercising muscle (open circles). Open triangles indicate that between 17,000
and 22,000 ft., abnormally high levels of ROS are predicted in up to 25% of exercising muscle (in regions with highest metabolic capacity in relation
to O2 transport). The closed triangle (23,000 ft.) indicates high ROS in 25 to 50% of muscle. The open square (24,000 ft.) indicates 50–75% of muscle
has high levels of ROS and filled squares (25,000–30,000 ft.) show that 75–100% of muscle regions express high levels of ROS (see text for more
details). B: shows in more detail the percentage of exercising muscle that generates abnormally high levels of ROS at each altitude.
doi:10.1371/journal.pone.0111068.g005
Impact of Mitochondrial PO2 on ROS Generation
PLOS ONE | www.plosone.org 7 November 2014 | Volume 9 | Issue 11 | e111068
Author Contributions
Conceived and designed the experiments: IC PDW VS MC JR DGC JT.
Performed the experiments: IC PDW VS. Analyzed the data: IC PDW VS.
Contributed reagents/materials/analysis tools: IC PDW VS. Wrote the
paper: IC PDW VS MC JR DGC JT.
References
1. Waypa GB, Marks JD, Guzy R, Mungai PT, Schriewer J, et al. (2010) Hypoxia
triggers subcellular compartmental redox signaling in vascular smooth muscle
cells. Circ Res 106: 526–535.
2. Bailey DM, Young IS, McEneny J, Lawrenson L, Kim J, et al. (2004) Regulation
of free radical outflow from an isolated muscle bed in exercising humans.
American Journal of Physiology - Heart and Circulatory Physiology 287:
H1689–H1699.
3. Koechlin C, Maltais F, Saey D, Michaud A, LeBlanc P, et al. (2005)
Hypoxaemia enhances peripheral muscle oxidative stress in chronic obstructive
pulmonary disease. Thorax 60: 834–841.
4. Cherniack NS (2004) Oxygen sensing: applications in humans. Journal of
Applied Physiology 96: 352–358.
5. Semenza GL (2011) Oxygen Sensing, Homeostasis, and Disease. New England
Journal of Medicine 365: 537–547.
6. Schumacker PT (2011) Lung cell hypoxia: role of mitochondrial reactive oxygen
species signaling in triggering responses. Proc Am Thorac Soc 8: 477–484.
7. Richardson RS, Noyszewski EA, Kendrick KF, Leigh JS, Wagner PD (1995)
Myoglobin O2 desaturation during exercise. Evidence of limited O2 transport.
J Clin Invest 96: 1916–1926.
8. Tran TK, Sailasuta N, Hurd R, Jue T (1999) Spatial distribution of
deoxymyoglobin in human muscle: an index of local tissue oxygenation. NMR
Biomed 12: 26–30.
9. Mik EG (2013) Measuring Mitochondrial Oxygen Tension: From Basic
Principles to Application in Humans. Anesth Analg 117: 834–846.
10. Wagner PD (1996) Determinants of maximal oxygen transport and utilization.
Annu Rev Physiol 58: 21–50.
11. Wagner PD (1993) Algebraic analysis of the determinants of VO2max. Respir
Physiol 93: 221–237.
12. Cano I, Mickael M, Gomez-Cabrero D, Tegne´r J, Roca J, et al. (2013)
Importance of mitochondrial in maximal O2 transport and utilization: A
theoretical analysis. Respiratory Physiology & Neurobiology 189: 477–483.
13. Wilson DF, Erecinska M, Drown C, Silver IA (1977) Effect of oxygen tension on
cellular energetics. American Journal of Physiology - Cell Physiology 233: C135–
C140.
14. Gnaiger E, Lassnig B, Kuznetsov A, Rieger G, Margreiter R (1998)
Mitochondrial oxygen affinity, respiratory flux control and excess capacity of
cytochrome c oxidase. J Exp Biol 201: 1129–1139.
15. Scandurra FM, Gnaiger E (2010) Cell respiration under hypoxia: facts and
artefacts in mitochondrial oxygen kinetics. Adv Exp Med Biol 662: 7–25.
16. Cano I, Wagner PD, Roca J (2014) Effects of Lung and Muscle Heterogeneities
on Maximal O2 Transport and Utilization. The Journal of Physiology (2nd
revision).
17. Selivanov VA, Votyakova TV, Pivtoraiko VN, Zeak J, Sukhomlin T, et al.
(2011) Reactive Oxygen Species Production by Forward and Reverse Electron
Fluxes in the Mitochondrial Respiratory Chain. PLoS Comput Biol 7:
e1001115.
18. Selivanov Va, Votyakova TV, Zeak Ja, Trucco M, Roca J, et al. (2009)
Bistability of mitochondrial respiration underlies paradoxical reactive oxygen
species generation induced by anoxia. PLoS computational biology 5: e1000619.
19. Selivanov VA, Cascante M, Friedman M, Schumaker MF, Trucco M, et al.
(2012) Multistationary and oscillatory modes of free radicals generation by the
mitochondrial respiratory chain revealed by a bifurcation analysis. PLoS
Comput Biol 8: e1002700.
20. Berkelhamer SK, Kim GA, Radder JE, Wedgwood S, Czech L, et al. (2013)
Developmental differences in hyperoxia-induced oxidative stress and cellular
responses in the murine lung. Free Radic Biol Med 61C: 51–60.
21. Gore A, Muralidhar M, Espey MG, Degenhardt K, Mantell LL (2010)
Hyperoxia sensing: from molecular mechanisms to significance in disease.
J Immunotoxicol 7: 239–254.
22. Sutton JR, Reeves JT, Wagner PD, Groves BM, Cymerman A, et al. (1988)
Operation Everest II: oxygen transport during exercise at extreme simulated
altitude. J Appl Physiol 64: 1309–1321.
23. Sinha S, Ray US, Saha M, Singh SN, Tomar OS (2009) Antioxidant and redox
status after maximal aerobic exercise at high altitude in acclimatized lowlanders
and native highlanders. Eur J Appl Physiol 106: 807–814.
24. Magalhaes J, Ascensao A, Viscor G, Soares J, Oliveira J, et al. (2004) Oxidative
stress in humans during and after 4 hours of hypoxia at a simulated altitude of
5500 m. Aviat Space Environ Med 75: 16–22.
25. Joanny P, Steinberg J, Robach P, Richalet JP, Gortan C, et al. (2001) Operation
Everest III (Comex’97): the effect of simulated sever hypobaric hypoxia on lipid
peroxidation and antioxidant defence systems in human blood at rest and after
maximal exercise. Resuscitation 49: 307–314.
26. Dejours P, Kayser C (1966) Respiration: Oxford University Press.
27. Weibel ER, Taylor CR, Gehr P, Hoppeler H, Mathieu O, et al. (1981) Design of
the mammalian respiratory system. IX. Functional and structural limits for
oxygen flow. Respir Physiol 44: 151–164.
28. Weibel ER (1984) The Pathway for Oxygen: Structure and Function in the
Mammalian Respiratory System: Harvard University Press.
29. Welch HG (1982) Hyperoxia and human performance: a brief review. Med Sci
Sports Exerc 14: 253–262.
30. Wilson GD, Welch HG (1975) Effects of hyperoxic gas mixtures on exercise
tolerance in man. Med Sci Sports 7: 48–52.
31. Wagner PD, Hedenstierna G, Bylin G (1987) Ventilation-perfusion inequality in
chronic asthma. Am Rev Respir Dis 136: 605–612.
32. Briscoe WA (1959) A method for dealing with data concerning uneven
ventilation of the lung and its effects on blood gas transfer. Journal of Applied
Physiology 14: 291–298.
33. Wagner PD, Laravuso RB, Uhl RR, West JB (1974) Continuous distributions of
ventilation-perfusion ratios in normal subjects breathing air and 100 per cent
O2. J Clin Invest 54: 54–68.
34. West JB, Dollery CT (1960) Distribution of blood flow and ventilation-perfusion
ratio in the lung, measured with radioactive CO2. Journal of Applied Physiology
15: 405–410.
35. West JB (2002) Highest permanent human habitation. High Alt Med Biol 3:
401–407.
36. Gough DR, Cotter TG (2011) Hydrogen peroxide: a Jekyll and Hyde signalling
molecule. Cell Death and Dis 2: e213.
37. Simon HU, Haj-Yehia A, Levi-Schaffer F (2000) Role of reactive oxygen species
(ROS) in apoptosis induction. Apoptosis 5: 415–418.
38. Kang MA, So EY, Simons AL, Spitz DR, Ouchi T (2012) DNA damage induces
reactive oxygen species generation through the H2AX-Nox1/Rac1 pathway.
Cell Death Dis 3: e249.
39. Oshikawa J, Urao N, Kim HW, Kaplan N, Razvi M, et al. (2010) Extracellular
SOD-derived H2O2 promotes VEGF signaling in caveolae/lipid rafts and post-
ischemic angiogenesis in mice. PLoS One 5: e10189.
40. Giannoni E, Buricchi F, Raugei G, Ramponi G, Chiarugi P (2005) Intracellular
reactive oxygen species activate Src tyrosine kinase during cell adhesion and
anchorage-dependent cell growth. Mol Cell Biol 25: 6391–6403.
41. Turan N, Kalko S, Stincone A, Clarke K, Sabah A, et al. (2011) A Systems
Biology Approach Identifies Molecular Networks Defining Skeletal Muscle
Abnormalities in Chronic Obstructive Pulmonary Disease. PLoS Comput Biol 7:
e1002129.
42. Rodriguez DA, Kalko S, Puig-Vilanova E, Perez-Olabarria M, Falciani F, et al.
(2012) Muscle and blood redox status after exercise training in severe COPD
patients. Free Radic Biol Med 52: 88–94.
43. Hare JM (2004) Nitroso–Redox Balance in the Cardiovascular System. New
England Journal of Medicine 351: 2112–2114.
44. Singel DJ, Stamler JS (2004) Blood traffic control. Nature 430: 297–297.
45. Rabinovich R, Bastos R, Ardite E, Llina`s L, Orozco-Levi M, et al. (2007)
Mitochondrial dysfunction in COPD patients with low body mass index. The
European respiratory journal: official journal of the European Society for
Clinical Respiratory Physiology 29: 643–650.
46. Puente-Maestu L, Perez-Parra J, Godoy R, Moreno N, Tejedor A, et al. (2009)
Abnormal transition pore kinetics and cytochrome C release in muscle
mitochondria of patients with chronic obstructive pulmonary disease. Am J Re-
spir Cell Mol Biol 40: 746–750.
47. Meyer A, Zoll J, Charles AL, Charloux A, de Blay F, et al. (2013) Skeletal muscle
mitochondrial dysfunction during chronic obstructive pulmonary disease: central
actor and therapeutic target. Exp Physiol 98: 1063–1078.
48. Raymond J, Segre D (2006) The effect of oxygen on biochemical networks and
the evolution of complex life. Science 311: 1764–1767.
49. Baldwin JE, Krebs H (1981) The evolution of metabolic cycles. Nature 291:
381–382.
50. Koch LG, Britton SL (2008) Aerobic metabolism underlies complexity and
capacity. J Physiol 586: 83–95.
51. Powers SK, Nelson WB, Hudson MB (2011) Exercise-induced oxidative stress in
humans: cause and consequences. Free Radic Biol Med 51: 942–950.
Impact of Mitochondrial PO2 on ROS Generation
PLOS ONE | www.plosone.org 8 November 2014 | Volume 9 | Issue 11 | e111068
